YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.

Other languages Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Equities

002675

CNE100001DP5

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
13.46 ^CNY	-3.24%		-2.68%	-26.57%

07/05	US FDA Grants Clinical Trial Approval for Dongcheng Biochemicals' Injection	MT
29/04	Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US FDA Grants Clinical Trial Approval for Dongcheng Biochemicals' Injection	07/05
Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug	29/04
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/04
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug in Singapore	11/04
Dongcheng Pharmaceutical to Buy Liver Drug Rights from Affiliate for 85 Million Yuan	21/02
Dongcheng Pharmaceutical Unit to Buy Rights to Tumor-Detecting Drug for 63 Million Yuan; Shares Up 10%	06/02
Dongcheng Pharma's Singaporean Unit Gets FDA's Nod to Carry Out Trial on 68GaLNC1007 Injection	29/01
Yantai Dongcheng Pharma Unit Secures License for Radioactive Cargo Transport	28/12
Dongcheng Pharmaceutical Gets Nod to Trial Tumor Drug in China	05/12
Yantai Dongcheng Pharmaceutical's Unit Ties Up With Chinese Physics Institute for Electron Accelerator Development	23/11
Yantai Dongcheng Pharma Gets Nod to Trial Prostate Cancer Treatment in China	21/11
Dongcheng Pharma Forms Medical Isotopes JV With Germany’s Eckert & Ziegler	15/11
Dongcheng Biochemicals Unit Gets Nod to Trial Prostate Cancer Drug in Singapore	10/11
Dongcheng Biochemicals' Unit Gets Nod to Market Dalteparin Sodium Injection	01/11
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26
Dongcheng Biochemicals Receives Good Manufacturing Practice Certificate from Germany	18/23/18
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23
Yantai Dongcheng Pharma Registers Raw Material For Deep Vein Thrombosis Drug	01/23/01
Yantai Dongcheng Pharma Registers Deep Vein Thrombosis Drug	13/23/13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Equities

002675

CNE100001DP5

Other languages

Filters